ATRECA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0902 USD | -6.23% |
|
+12.75% | -31.67% |
| 17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
| 10/04 | North American Morning Briefing : Traders Await -2- | DJ |
Chart calendar Atreca, Inc.
1e4c40aa5d065dca0533.M1yVbkbdweI27q-GQRXE3MsrKrN18efkmjEnB_1mzNU.SRDyJzXwqbEDh_a1Bya3v45fbtQXyIXU31p3Ma4qp5hlLbhcDam2iFiH_g~02c259d1e6d493ac75815b1442c12e6b
Upcoming events on Atreca, Inc.
Past events on Atreca, Inc.
| 08/04/2024 10:30 pm | Extraordinary Shareholders Meeting |
| 28/03/2024 10:30 pm | Extraordinary Shareholders Meeting - Restructuring Vote |
| 15/11/2023 03:00 am | Q3 2023 Earnings Release |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 13/06/2023 | Annual General Meeting |
| 04/06/2023 08:15 pm | American Society of Clinical Oncology Conference - Abstract Number: 2505 |
| 20/04/2023 07:30 pm | Canaccord Genuity Horizons in Oncology Virtual Conference - Panel |
| 31/03/2023 02:00 am | Q4 2022 Earnings Call |
| 30/03/2023 01:35 am | Q4 2022 Earnings Release |
| 07/03/2023 07:40 pm | Cowen Health Care Conference |
| 01/12/2022 08:10 pm | Evercore ISI HealthCONx Conference |
| 15/11/2022 06:30 pm | Stifel Healthcare Conference |
| 12/11/2022 01:10 am | Cowen IO Next Summit |
| 11/11/2022 03:00 am | Q3 2022 Earnings Release |
| 10/11/2022 | Society for Immunotherapy of Cancer Meeting - Abstract Number 717 |
| 10/11/2022 | Society for Immunotherapy of Cancer Meeting - Abstract Number 1194 |
| 14/09/2022 11:30 pm | Baird Global Healthcare Conference |
| 14/09/2022 12:00 am | H.C. Wainwright Global Investment Conference |
| 07/09/2022 | ADC World Conference |
| 17/08/2022 | Interim 2022 Earnings Release (Projected) |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,14 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -86,5 -89,2 3.02% | -106 -109 3.16% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -72,6 -70,4 -3.07% | -88,9 -89,5 0.74% | -110 -111 0.21% | -98,3 -102 3.69% | -81,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -67,5 -66,3 -1.8% | -86,3 -86,9 0.61% | -109 -110 0.39% | -97,2 -101 3.7% | -80,0 |
|
Net income Million USD | Released Forecast Spread | -37,9 | -67,5 -66,3 -1.8% | -86,3 -86,9 0.61% | -109 -110 0.39% | -97,2 -101 3.7% | -80,0 |
|
EPS USD | Released Forecast Spread | -108 | -4,26 -3,11 -36.83% | -2,70 -2,73 0.92% | -2,95 -2,89 -1.96% | -2,52 -2,46 -2.54% | -2,04 |
| Announcement Date | 24/04/19 | 11/03/20 | 25/02/21 | 03/03/22 | 29/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -26,1 -27,5 5.1% | -28,1 -28,4 0.9% | -25,7 -30,4 15.56% | -28,0 -27,2 -3.05% | -21,9 -29,0 24.38% | -21,5 -24,8 13.18% | -18,5 -23,0 19.68% | -14,9 -15,5 4.01% | ||||||
|
EBIT Million USD | Released Forecast Spread | -27,5 -28,1 2.03% | -29,5 -29,0 -1.84% | -25,7 -29,8 13.9% | -28,0 -27,6 -1.53% | -23,3 -28,2 17.44% | -21,3 -25,1 15.01% | -21,5 -21,8 1.38% | -19,8 -22,4 11.98% | -15,8 -15,2 -3.93% | -14,3 | -9,00 | -9,80 | -10,0 | -10,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,4 -27,9 1.81% | -29,5 -28,9 -2.18% | -24,9 -29,8 16.54% | -27,9 -26,8 -4.03% | -23,1 -28,1 17.94% | -21,3 -24,9 14.28% | -21,0 -21,5 2.46% | -19,2 -22,2 13.68% | -36,2 -14,9 -142.61% | -13,9 | -8,80 | -9,50 | -9,80 | -10,5 |
|
Net income Million USD | Released Forecast Spread | -27,4 -27,9 1.81% | -29,5 -28,9 -2.18% | -24,9 -29,8 16.54% | -27,9 -26,7 -4.52% | -23,1 -28,1 17.94% | -21,3 -24,9 14.28% | -21,0 -21,5 2.46% | -19,2 -22,2 13.68% | -36,2 -14,9 -142.61% | -13,9 | -8,80 | -9,50 | -9,80 | -10,5 |
|
EPS USD | Released Forecast Spread | -0,74 -0,74 0.17% | -0,79 -0,75 -4.81% | -0,65 -0,79 17.33% | -0,72 -0,70 -3.23% | -0,60 -0,73 17.24% | -0,55 -0,59 7.01% | -0,54 -0,56 3.57% | -0,49 -0,57 13.6% | -0,92 -0,38 -139.4% | -0,35 | -0,22 | -0,15 | -0,15 | -0,16 |
| Announcement Date | 02/11/21 | 03/03/22 | 11/05/22 | 08/08/22 | 10/11/22 | 29/03/23 | 10/05/23 | 10/08/23 | 14/11/23 | - | - | - | - | - |
More events
Past sector events for Atreca, Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCEL Stock
- Calendar Atreca, Inc.
